Home » » Pfizer's hemophilia therapy reduces bleeding in late-stage study https://ift.tt/Yq8pE9D

Pfizer's hemophilia therapy reduces bleeding in late-stage study https://ift.tt/Yq8pE9D

No comments
The estimated prevalence in the United States is 12 cases per 100,000 males for hemophilia A and 3.7 cases per 100,000 males for hemophilia B. The current standard of care requires regular infusion of the missing proteins.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/PTjBZ3E
Share:

No comments:

Post a Comment

Search This Blog
Powered by Blogger.

Labels

Labels

Blog Archive

Recent Posts

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.